Table of Contents

company-logo

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad Laboratories Dividend Announcement

• Bio-Rad Laboratories does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Bio-Rad Laboratories dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Bio-Rad Laboratories Dividend History

Bio-Rad Laboratories Dividend Yield

Bio-Rad Laboratories current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bio-Rad Laboratories stock? Use our calculator to estimate your expected dividend yield:

Bio-Rad Laboratories Financial Ratios

P/E ratio-12.06
PEG ratio1.85
P/B ratio1.25
ROE-9.72%
Payout ratio-10976.21%
Current ratio6.14
Quick ratio4.52
Cash Ratio0.83

Bio-Rad Laboratories Dividend FAQ

Does Bio-Rad Laboratories stock pay dividends?
Bio-Rad Laboratories does not currently pay dividends to its shareholders.
Has Bio-Rad Laboratories ever paid a dividend?
No, Bio-Rad Laboratories has no a history of paying dividends to its shareholders. Bio-Rad Laboratories is not known for its dividend payments.
Why doesn't Bio-Rad Laboratories pay dividends?
There are several potential reasons why Bio-Rad Laboratories would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bio-Rad Laboratories ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bio-Rad Laboratories has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bio-Rad Laboratories a dividend aristocrat?
Bio-Rad Laboratories is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bio-Rad Laboratories a dividend king?
Bio-Rad Laboratories is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bio-Rad Laboratories a dividend stock?
No, Bio-Rad Laboratories is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bio-Rad Laboratories stocks?
To buy Bio-Rad Laboratories you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Bio-Rad Laboratories stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.